Nerve growth factor (NGF) and its precursor form, proNGF, are critical for neuronal survival
and cognitive function. In the brain, proNGF is the only detectable form of NGF …

Parkinson's disease (PD) is characterized by the presence of insoluble protein clusters
containing α-synuclein. Impairment of mitochondria, endoplasmic reticulum, autophagy and …

The accumulation and aggregation of α-synuclein (α-SYN) is a common characteristic of
synucleinopathies, such as Parkinson's Disease (PD), Dementia with Lewy Bodies (DLB) or …

Parkinson's disease (PD) is an aging-associated neurodegenerative disorder with the
hallmark of abnormal aggregates of alpha-synuclein (α-syn) in Lewy bodies (LBs) and Lewy …

Defects in motor protein-mediated neuronal transport mechanisms have been implicated in
a number of neurodegenerative disorders but remain relatively little studied in Alzheimer's …

The formation of oligomers and aggregates of overexpressed or mutant α-synuclein play a
role in the degeneration of dopaminergic neurons in Parkinson's disease by causing …

Alzheimer's disease (AD) is a neurodegenerative disease that seriously affects the life and
health of the elderly. Studies have found that circular RNAs (circRNAs) are associated with …

Alzheimer's disease (AD) is marked by the gradual and age-related deterioration of nerve
cells in the central nervous system. The histopathological features observed in the brain …

Rotenone, a classic mitochondrial complex I inhibitor, leads to dopaminergic neuronal death
resulting in a Parkinson's-like-disease. Docosahexaenoic acid (DHA) has shown …

Parkinson's disease (PD) is a complex disorder, primarily of idiopathic origin, with
environmental stressors like rotenone and manganese linked to its development. This study …